Serum Human \(\beta\) Defensin (HBD-2) and Osteocalcin Levels in Menopausal Iraqi Women with Osteopenia

NoorAlhuda Kh Ibrahim\(^{1,*}\), Wasnaa J. Mohammad\(^{1}\), Sanan Th. Abdalwahab\(^{2}\) and Anfal S. Sameen\(^{3}\)

\(^{1}\)University of Baghdad, College of Nursing, Department of Basic Sciences, Baghdad, Iraq.
\(^{2}\)Ibn Sina University of Medical and Pharmaceutical Sciences, College of Dentistry, Iraq.
\(^{3}\)Chemical Specialists in the Iraqi Ministry of Health, Iraq.

Abstract

Background and Purpose: Osteopenia (OP) is a chronic and advanced condition that is often described by diminished bone mineral density (BMD), deteriorated bone tissue microarchitecture, and an elevated risk of fracture. The low molecular weight antimicrobial peptides known as Human Defensin (HBD-2) proteins are produced locally by keratinocytes in various tissues, including skin, mucosa, and bones. Osteocalcin, often called bone gamma-carboxyglutamic acid-containing protein (BGLAP), is a tiny (49 amino acids) noncollagenous protein hormone in bone and dentin. It was initially discovered to be a calcium-binding protein. Material and Methods: Prospective study to evaluate the osteoblast’s ability to produce and release osteocalcin makes it a noncollagenous protein, and has primary physiological roles include calcium ion homeostasis, maintaining an average rate of bone mineralization, preventing the aberrant development of hydroxyapatite crystals, and participating in bone remodeling via a negative feedback loop. In menopausal women with osteopenia, this study evaluates the osteocalcin and human beta-defensin 2 for their diagnostic potential. A small amount of venous blood, about 5 ml, was added to the tube and centrifuged for five minutes at a speed of 3 \(\times\) 103 rpm. The serum was put into an Eppendorf tube and stored in a freezer at -20 \(^\circ\)C before being tested. With the help of the specified equation, the body mass index is determined. Findings and Conclusion: Increasing serum HBD 2, osteocalcin levels in postmenopausal women with osteopenia plays an essential role in developing osteopenia to osteoporosis. Differences in serum levels of alkaline phosphatase were seen among patients (as a sample) and controls; serum levels of HBD2 and osteocalcin were considerably lower in controls than in patients (p 0.01).

Copyright © 2023 the Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0.

References

  1. Zhang, S., Huang, X., Zhao, X., Li, B., Cai, Y., Liang, X., & Wan, Q. (2022). Effect of exercise on bone mineral density among patients with osteoporosis and osteopenia: A systematic review and network meta-analysis. Journal of Clinical Nursing, 31(15-16), 2100-2111.
  2. Khinda, R., Valecha, S., Kumar, N., Walia, J. P. S., Singh, K., Sethi, S., … & Mastana, S. (2022). Prevalence and predictors of osteoporosis and osteopenia in postmenopausal women of Punjab, India. International Journal of Environmental Research and Public Health, 19(5), 2999.
  3. Teng, Z., Zhu, Y., Yu, X., Liu, J., Long, Q., Zeng, Y., & Lu, S. (2021). An analysis and systematic review of sarcopenia increasing osteopenia risk. PLoS One, 16(4), e0250437.
  4. Khan, I. A., & Bordoni, B. (2022). Histology, Osteoclasts. In StatPearls [Internet]. StatPearls Publishing.
  5. Swaminathan, R. (2001). Biochemical markers of bone turnover. Clinical Chimica Acta, 313, 95-105.
  6. Peng, Y., Li, L., Yuan, Q., Gu, P., You, Z., Zhuang, A., & Bi, X. (2020). Effect of bifunctional β defensin 2-modified scaffold on bone defect reconstruction. ACS Omega, 5(8), 4302-4312.
  7. Warnke, P. H., Springer, I. N., Russo, P. A., Wiltfang, J., Essig, H., Kosmahl, M., … & Acil, Y. (2006). Innate immunity in human bone. Bone, 38(3), 400-408.
  8. Wang, M., Zeng, W., Zhang, Z., Zhang, W., Su, H., Zhang, Z., … Shi, Q. (2021). The improvement of immune effect of recombinant human beta-defensin 2 on hepatitis B vaccine in mice. Viral Immunology, 34(2), 96-111.
  9. Luthje, F. L., Jensen, L. K., Jensen, H. E., & Skovgaard, K. (2020). The inflammatory response to bone infection-a review based on animal models and human patients. Journal of Pathology, Microbiology and Immunology, 128(4), 275-286.
  10. World Health Organization. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [meeting held in Rome from 22 to 25 June 1992]. World Health Organization.
  11. MedCalc Statistical Software version 16.4.3 (2016). MedCalc Software bvba, Ostend, Belgium. Available at https://www.medcalc.org.
  12. Rogers, R. G. (1987). SAS/PC: An overview with demographic applications. Social Science Microcomputer Review, 5(1), 1-10.
  13. Khinda, R., Valecha, S., Kumar, N., Walia, J. P. S., Singh, K., Sethi, S., … Mastana, S. (2022). Prevalence and predictors of osteoporosis and osteopenia in postmenopausal women of Punjab, India. International Journal of Environmental Research and Public Health, 19(5), 2999.
  14. Peng, Y., Li, L., Yuan, Q., Gu, P., You, Z., Zhuang, A., & Bi, X. (2020). Effect of bifunctional β defensin 2-modified scaffold on bone defect reconstruction. ACS Omega, 5(8), 4302-4312.
  15. Zhou, J., Li, L., Cui, D., Xie, X., Yang, W., & Yan, F. (2021). Effects of Gold Nanoparticles Combined Human β-defensin 3 on The Alveolar Bone of Experimental Periodontitis. Available at https://doi.org/10.21203/rs.3.rs-394810/v1.
  16. Bahroudi, M., Bakhshi, B., Soudi, S., & Najar-Peerayeh, S. (2020). Antibacterial and antibiofilm activity of bone marrow-derived human mesenchymal stem cells secretome against Vibrio cholerae. Microbial Pathogenesis, 139, 103867.
  17. Zhou, M., Ma, X., Li, H., Pan, X., Tang, J., Gao, Y., … & Jia, W. (2009). Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. European Journal of Endocrinology, 161(5), 723-729.
  18. Gundberg, C. M., Looker, A. C., Nieman, S. D., & Calvo, M. S. (2002). Patterns of osteocalcin and bone-specific alkaline phosphatase by age, gender, and race or ethnicity. Bone, 31(6), 703-708.
  19. Vanderschueren, D., Gevers, G., Raymaekers, G., Devos, P., & Dequeker, J. (1990). Sex- and age-related changes in bone and serum osteocalcin. Calcified Tissue International, 46(3), 179-182.
  20. Atalay, S., Elci, A., Kayadibi, H., Onder, C. B., & Aka, N. (2012). Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Annals of Laboratory Medicine, 32(1), 23-30.
  21. Park, S. G., Jeong, S. U., Lee, J. H., Ryu, S. H., Jeong, H. J., Sim, Y. J., … & Kim, G. C. (2018). The changes of CTX, DPD, osteocalcin, and bone mineral density during the postmenopausal period. Annals of rehabilitation medicine, 42(3), 441-448.
  22. Moser, S. C., & van der Eerden, B. C. (2019). Osteocalcin a versatile bone-derived hormone. Frontiers in Endocrinology, 9, 794.
  23. Moon, J. S., Jin, M. H., & Koh, H. M. (2021). Association between serum osteocalcin levels and metabolic syndrome according to the menopausal status of Korean women. Journal of Korean Medical Science, 36(8), e56.
  24. Corrado, A., Rotondo, C., Cici, D., Berardi, S., & Cantatore, F. P. (2021). Effects of different vitamin D supplementation schemes in post-menopausal women: A monocentric open-label randomized study. Nutrients, 13(2), 380.
  25. Malabanan, A. O., & Holick, M. F. (2003). Vitamin D and bone health in postmenopausal women. Journal of Women’s Health (Larchmt), 12(2), 151-156.

Indexings

About the Journal

The Azerbaijan Pharmaceutical and Pharmacotherapy Journal (APPJ) aims to serve as a leading platform for the see more

From the Editor-in-Chief's Desk

From 2001 to 2021, the Azerbaijan Pharmaceutical and Pharmacotherapy Journal (APPJ) had a long-standing tradition of see more

Special Issues

Do you see an emerging area of research that needs to be highlighted? Or an existing research area that see more

Special Issue Open for Submission